Therefore, we aimed to investigate the effects of BRD4 on hepatocellular lipotoxicity, as well as to explore whether BRD4 is involved in activating the NLRP3 inflammasome and promoting hepatocyte pyroptosis during MASLD pathogenesis. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.